Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.91 USD | +0.55% | -2.27% | -1.09% |
Apr. 24 | Andersons Insider Sold Shares Worth $531,429, According to a Recent SEC Filing | MT |
Mar. 01 | BACKGROUND/Capital Markets Day at Bayer: To split up or not? | DP |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Fishing & Farming
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.09% | 1.92B | B- | ||
-11.82% | 1.66B | B | ||
+3.85% | 1.35B | - | D | |
-15.38% | 991M | - | - | |
-10.34% | 998M | - | - | |
-9.65% | 975M | - | B | |
-17.09% | 877M | B+ | ||
+10.38% | 732M | - | A- | |
-2.24% | 441M | - | - | |
-66.86% | 357M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ANDE Stock
- Ratings The Andersons, Inc.